The level of plasma soluble CX3CL1 was markedly higher in patients with mild to moderate AD than in those with severe AD [225], and the level of tissue CX3CL1 was lower in the hippocampus and the frontal cortex of AD patients [226]. This evidence concerns the gene CX3CL1 and Alzheimer disease.